Skip to content
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
Menu
  • About
  • Team
  • Clinical Trials
  • KRN-101
  • Investing
  • Press & Updates
  • Contact
CSE: ABRT • FSE: VB50
CSE: ABRT
ABRT
Read more about the article Psychedelic Therapy isn’t Fringe Anymore

Psychedelic Therapy isn’t Fringe Anymore

  • Post author:Olly PP
  • Post published:October 22, 2022
  • Post category:Industry News

Continue ReadingPsychedelic Therapy isn’t Fringe Anymore
Read more about the article Can Psychedelics Cure?

Can Psychedelics Cure?

  • Post author:Olly PP
  • Post published:October 22, 2022
  • Post category:Industry News

Continue ReadingCan Psychedelics Cure?
Read more about the article The Lancet Commission on Ending Stigma and Discrimination in Mental Health

The Lancet Commission on Ending Stigma and Discrimination in Mental Health

  • Post author:Olly PP
  • Post published:October 22, 2022
  • Post category:Industry News

Continue ReadingThe Lancet Commission on Ending Stigma and Discrimination in Mental Health
Read more about the article The MHRA’s Innovation Passport

The MHRA’s Innovation Passport

  • Post author:Olly PP
  • Post published:October 12, 2022
  • Post category:Industry News

Continue ReadingThe MHRA’s Innovation Passport
Read more about the article Can Psilocybin Challenge Our Pharmaceutical Dependence?

Can Psilocybin Challenge Our Pharmaceutical Dependence?

  • Post author:Olly PP
  • Post published:October 12, 2022
  • Post category:Industry News

Continue ReadingCan Psilocybin Challenge Our Pharmaceutical Dependence?
Read more about the article The Magic Mushroom Experience: Taking Psilocybin for Science

The Magic Mushroom Experience: Taking Psilocybin for Science

  • Post author:Olly PP
  • Post published:October 10, 2022
  • Post category:Industry News

Continue ReadingThe Magic Mushroom Experience: Taking Psilocybin for Science
Read more about the article The Psychedelic Remedy for Chronic Pain

The Psychedelic Remedy for Chronic Pain

  • Post author:Olly PP
  • Post published:September 28, 2022
  • Post category:Industry News

Continue ReadingThe Psychedelic Remedy for Chronic Pain
Read more about the article Psychedelic Therapy could reduce Anxiety, Distress among Patients with Cancer

Psychedelic Therapy could reduce Anxiety, Distress among Patients with Cancer

  • Post author:Olly PP
  • Post published:September 27, 2022
  • Post category:Industry News

Continue ReadingPsychedelic Therapy could reduce Anxiety, Distress among Patients with Cancer
Read more about the article Psilocybin-Assisted Psychotherapy Treatment with Alcohol Use Disorder: A Randomized Clinical Trial

Psilocybin-Assisted Psychotherapy Treatment with Alcohol Use Disorder: A Randomized Clinical Trial

  • Post author:Olly PP
  • Post published:August 24, 2022
  • Post category:Industry News

Continue ReadingPsilocybin-Assisted Psychotherapy Treatment with Alcohol Use Disorder: A Randomized Clinical Trial
Read more about the article Psychedelic Drugs Global Market to Reach $7.03 Billion by 2026

Psychedelic Drugs Global Market to Reach $7.03 Billion by 2026

  • Post author:Olly PP
  • Post published:August 8, 2022
  • Post category:Industry News

Continue ReadingPsychedelic Drugs Global Market to Reach $7.03 Billion by 2026
  • 1
  • 2
  • 3
  • 4
  • …
  • 7
  • Go to the next page

Recent Posts

  • Albert Labs Management and Board of Director Announcement
  • Expansion of Drug Discovery and a Promising Pipeline
  • Albert Labs Announces Private Placement
  • Letter of Intent (LOI) for First-In-Human studies with iNGENÅ« CRO
  • Albert Labs Provides Corporate Update

Recent Comments

    Innovative mental health medicines for patients with unmet needs

    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy
    • Legal Disclaimer
    • Privacy Policy
    • Modern Slavery Statement
    • Cookie Policy

    © 2023 Albert Labs. All Rights Reserved

    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    • About
    • Team
    • Clinical Trials
    • KRN-101
    • Investing
    • Press & Updates
    • Contact
    Twitter Linkedin Youtube Envelope
    CSE:ABRT
    FSE: VB50
    CSE:ABRT
    FSE: VB50

    About Albert Labs

    We are a pharmaceutical company leveraging our drug development and clinical research expertise to accelerate the development of highly effective mental health medicines.

    If you would like support or more information around making an investment, please contact [email protected]

    Twitter Linkedin Youtube Envelope

    Complete this form to receive corporate updates and further details on how to invest in Albert Labs. By completing this form, you agree to our privacy policy.

    • This field is for validation purposes and should be left unchanged.
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope
    Twitter
    Youtube
    Linkedin
    Instagram
    Envelope

    By completing this form you agree to our privacy policy. You will be sent corporate updates and further details including how to invest in Albert Labs.